Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DP5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,001
Award facts
- Contract value 100% obligated
- $40,000.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,000.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Dupixent 300 mg/2 mL pens (2 mL vials). The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of December 1, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply an extensive range of medications and medical supplies to support military healthcare programs globally.
Dupixent (dupilumab) is a biologic immunosuppressant used to treat conditions including moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and certain types of asthma. The DLA procures this and other specialty pharmaceuticals through its Medical Supply Chain to support military healthcare systems, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's role as a primary pharmaceutical distributor for federal medical procurement is reflected in its portfolio of delivery orders covering diverse therapeutic domains, from diabetes and neurological medications to vaccines and specialized medical supplies, demonstrating the company's capability to meet varied federal health service requirements through competitive procurement mechanisms.
Quick answers
Who was awarded contract SPE2DR26F9DP5?
SPE2DR26F9DP5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26F9DP5 worth?
The government has obligated $40,001 on SPE2DR26F9DP5.
Is contract SPE2DR26F9DP5 an order under another contract?
Yes. SPE2DR26F9DP5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9DP5 competed?
The extent of competition for SPE2DR26F9DP5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award